Cargando…
Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy
OBJECTIVE: To determine the prevalence and clinical features of anti-HMGCR myopathy among patients with presumed limb-girdle muscular dystrophy (LGMD) in whom genetic testing has failed to elucidate causative mutations. METHODS: Patients with presumed LGMD and unrevealing genetic testing were select...
Autores principales: | Mohassel, Payam, Landon-Cardinal, Océane, Foley, A. Reghan, Donkervoort, Sandra, Pak, Katherine S., Wahl, Colleen, Shebert, Robert T., Harper, Amy, Fequiere, Pierre, Meriggioli, Matthew, Toro, Camilo, Drachman, Daniel, Allenbach, Yves, Benveniste, Olivier, Béhin, Anthony, Eymard, Bruno, Lafôret, Pascal, Stojkovic, Tanya, Mammen, Andrew L., Bönnemann, Carsten G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292490/ https://www.ncbi.nlm.nih.gov/pubmed/30588482 http://dx.doi.org/10.1212/NXI.0000000000000523 |
Ejemplares similares
-
Anti-HMGCR Myopathy
por: Mohassel, Payam, et al.
Publicado: (2018) -
Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies: Inconstant Exposure to Statin
por: Allenbach, Yves, et al.
Publicado: (2014) -
Next-generation sequencing still needs our generation's clinicians
por: Foley, A. Reghan, et al.
Publicado: (2015) -
Hypoglycemia in patients with congenital muscle disease
por: Hayes, Leslie H., et al.
Publicado: (2020) -
Limb girdle muscular disease caused by HMGCR mutation and statin myopathy treatable with mevalonolactone
por: Yogev, Yuval, et al.
Publicado: (2023)